Events
2023 Amsterdam Immunogenicity & Tolerance Seminar
Posted on April 4, 2023 by Elena IemmaPlease join us for the 2023 Amsterdam Immunogenicity & Tolerance Seminar! The AIT2023 organizing committee is excited to share that the Seminar will take place on Friday, November 10th from 10:00AM – 6:00PM European Time, at the Hilton Apollolaan in Amsterdam.Read moreWestin Immunogenicity Seminar 2023
Posted on April 4, 2023 by Elena IemmaThe 15th annual 2023 Westin Immunogenicity Seminar will be taking place on Friday, September 29th. The precise details, speakers and agenda will be announced soon- in the meantime, please Save the Date!Read moreEpiVax Turns 25! *Updated with Pictures!*
Posted on March 8, 2023 by Admin EpivaxUpdated: A big THANK YOU to everyone who joined us for our 25th Anniversary Party, held at our Providence, RI headquarters. We heard from good friends Vibha Jawa, Executive Director at Bristol Myers Squibb, and Seth Lederman, CEO of TONIX Pharmaceuticals, on the future of immunogenicity; new therapeutics, new vaccines, and new opportunities to improve human health. ...Read moreAmsterdam Immunogenicity & Tolerance Seminar November 18, 2022 **Updated with Pictures and Recordings!****
Posted on November 18, 2022 by Riley NolanAmsterdam Immunogenicity & Tolerance Seminar November 18, 2022 **Updated with Pictures and Recordings!****Read moreAAPS PharmSci 360, October 16-19, 2022 **Updated with Pictures!**
Posted on October 17, 2022 by Riley NolanWe had a blast at AAPS PharmSci 360 in Boston! Thank you to everyone that attended our talks and poster sessions, and stopped by our booth or cocktail reception at Legal Seafoods! Pictures below! Talks: Anne De Groot, M.D., EpiVax, Inc. Deimmunization and Immune Tolerance Strategies for Protein Therapeutics: Extension of Principles to Novel Therapeutic Modalities Amy Rosenberg, M.D., ...Read moreISV 2022 Computational Vaccinology Pre-Conference Workshop September 17th, 2022 ***Updated with Pictures and Recordings!******
Posted on July 22, 2022 by Riley NolanISV 2022 Computational Vaccinology Pre-Conference Workshop September 17th, 2022 ***Updated with Pictures and Recordings!******Read moreWestin Immunogenicity Seminar: September 9, 2022 **Updated with Pictures and Recordings!**
Posted on July 4, 2022 by Riley NolanWestin Immunogenicity Seminar: September 9, 2022 **Updated with Pictures and Recordings!**Read more1st Annual Tregitope Summit – May 16, 2022 **Updated with Photos!**
Posted on May 18, 2022 by Riley Nolan1st Annual Tregitope Summit - May 16, 2022 **Updated with Photos!**Read moreAAPS NBC, May 9-12 2022
Posted on May 5, 2022 by Riley NolanThe EpiVax team is excited to in-person at AAPS NBC 2022 in Anaheim, CA! Interested in connecting? Consider stopping by one of our presentations, or say hello to our team at Booth #301 in the exhibit hall! Additionally, you can request a meeting through the Connect360 portal. Our team would welcome the opportunity to hear about your ...Read moreGordon Research Conference on Biotherapeutics and Vaccines Development, March 2022
Posted on April 20, 2022 by Riley NolanGordon Research Conference on Biotherapeutics and Vaccines Development, March 2022Read moreEpiVax Women in Biotechnology Summit 2022
Posted on March 17, 2022 by Riley NolanAs a woman-led and women-owned company in biotech, EpiVax is a statistical outlier in the male dominated world of STEM. In an effort to address some of the gender disparities in our industry, Dr. Annie De Groot and EpiVax’s Katie Porter launched the “Recipes for Success” podcast in 2021 to encourage discussion on this important topic, ...Read moreAmsterdam Immunogenicity & Tolerance Seminar November 4-5, 2021 **Updated with Pictures and Recordings!**
Posted on November 4, 2021 by Riley NolanAmsterdam Immunogenicity & Tolerance Seminar November 4-5, 2021 **Updated with Pictures and Recordings!**Read moreBoulder Peptide Symposium – October 25-28, 2021
Posted on October 8, 2021 by Annie De GrootFrom October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will present the following posters! The posters will include a look at our What If Machine (WhIM), ...Read moreAAPS PharmSci360 2021 **Updated with pictures!**
Posted on October 8, 2021 by Annie De GrootEpiVax had a large contingent at AAPS PharmSci360 in Philadelphia! Check out the EpiVax itinerary below! Always nice to connect with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering Better Biologics: Does Nature Know Best? https://cdmcd.co/J6B7Lz Monday, October 18, 2021 3:30 PM – 4:30 PM ET Amy Rosenberg, MD Preparing for Success: Risk Assessment and ...Read more2021 International Society for Vaccines (ISV) Annual Virtual Congress
Posted on September 10, 2021 by Riley NolanEpiVax participated in the 2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021. The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community. Multiple EpiVax scientists presented throughout the three-day event, details below! EpiVax Director of Vaccine Research, Dr. Lenny Moise, co-chaired the Plenary Session 2 ...Read moreAAPS NBC Tech Challenge Talk: Engineering Better Biologics: Does Nature Know Best?
Posted on May 21, 2021 by Riley NolanAAPS NBC Tech Challenge Talk: Engineering Better Biologics: Does Nature Know Best?Read moreAAPS BPABC Community Presentation: In silico Immunogenicity Prediction for Protein and Peptide Therapeutics
Posted on March 11, 2021 by Riley NolanAimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is free for AAPS members. This work builds off Aimee’s AAPS PharmSci360 poster session on in silico approaches for handling ...Read moreFDA Webinar: Epitope Selection for Cancer Vaccines
Posted on February 17, 2021 by Riley NolanFDA Webinar: Epitope Selection for Cancer VaccinesRead moreFDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling
Posted on January 26, 2021 by Riley NolanFDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and SamplingRead moreAntibody Industrial Symposium (AIS) 2020 Virtual
Posted on November 16, 2020 by Annie De GrootAntibody Industrial Symposium (AIS) 2020 VirtualRead moreAmerican Association of Pharmaceutical Scientists (AAPS) – PharmSci360
Posted on October 27, 2020 by Annie De GrootEpiVax is proud to have three of our Director and Senior level scientists representing our work at the 2020 AAPS PharmSci 360 Meetings. There are several opportunities to catch up with them over the next two weeks including the following rapid fire talks: Brian Roberts, PhD Rapid Fire: https://www.eventscribe.com/2020/PharmSci360/index.asp?presTarget=1414336 What Contributes to Immunogenicity? The API, Formulation, or the Impurities? Wednesday, ...Read moreEpiVax CEO/CSO Annie De Groot wins AAPS 2020 Global Health Award
Posted on October 20, 2020 by Riley NolanWe are excited to share that our very own Annie De Groot was selected as a recipient of this year’s AAPS Global Health Award! View Annie’s acceptance speech here! The American Association of Pharmaceutical Scientists(AAPS) nominates one member annually for the Global Health Award, which recognizes AAPS members for their impact on their communities, both in the ...Read morePANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&A
Posted on September 23, 2020 by Annie De GrootPANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&ARead moreTIDES: Oligonucleotide and Peptide Therapeutics Virtual
Posted on September 23, 2020 by Annie De GrootTIDES: Oligonucleotide and Peptide Therapeutics VirtualRead moreRecorded: EpiVax EPV-CoV-19 Vaccine Webinar
Posted on September 21, 2020 by Annie De GrootThank you for your continued interest in the status of our EpiVax’s EPV-CoV-19 Vaccine Program. This event has passed! But do not fear, there is a recording of the session available for access. Kindly fill out the information form linked below and an email containing the recording will be forwarded to you within 24 hours of ...Read moreTIDES US Virtual 2020
Posted on August 20, 2020 by Annie De GrootWith the 2020 TIDES USA Virtual conference right around the corner, we at EpiVax are proud to sponsor this event, as we have year after year. Our CEO and leader in #FearlessScience Dr. Anne De Groot will be presenting a talk on a generic case study New Dogs/Old Tricks: Methods for Assessing the Immunogenicity of Peptide ...Read moreWebinar: Tregitopes are Everywhere – Even in SARS-CoV-2 (COVID-19)
Posted on June 11, 2020 by Annie De GrootWebinar: Tregitopes are Everywhere - Even in SARS-CoV-2 (COVID-19)Read moreWebinar: Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious Diseases
Posted on May 1, 2020 by Annie De GrootWebinar: Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious DiseasesRead moreWebinar: Science in the Time of COVID-19
Posted on April 7, 2020 by Annie De GrootWebinar: Science in the Time of COVID-19Read moreWorking from work, working from home, working towards a vaccine for COVID-19
Posted on March 27, 2020 by Annie De GrootWorking from work, working from home, working towards a vaccine for COVID-19Read moreBIO EUROPE March 23-25, 2020
Posted on March 2, 2020 by Annie De GrootBIO EUROPE March 23-25, 2020Read moreNFID Annual Conference on Vaccinology Research – March 23-25, 2020
Posted on February 28, 2020 by Annie De GrootThe 2020 meeting for the National Foundation for Infectious Diseases is taking place at the The Omni Shoreham Hotel in Washington DC, from March 23-25. During the meeting, EpiVax will be represented by Dr. Lenny Moise, director of Vaccines, Dr. Lauren Meyers, of the vaccine team, and Drasti Kanakia from the EpiVax lab team. Lauren will be ...Read moreAsiaTIDES: Oligonucleotide & Peptide Therapeutics february 24-26, 2020
Posted on February 19, 2020 by Annie De GrootDr. Brian Roberts, the Associate Scientific Director of Protein therapeutics at EpiVax will be heading to Kyoto, Japan for the 2020 AsiaTides meeting. While there, he will be hosting: An Overview of Peptides and Immunogenicity workshop on day 1, February 24 at 12:00PM during the Current Topics in Peptide Discovery and Development: A Focus on ...Read moreEuropean Immunogenicity Platform Symposium: Lisbon, Portugal February 17-19, 2020
Posted on February 3, 2020 by Annie De GrootDr. Anne De Groot will be going to Lisbon, Portugal to attend the European Immunogenicity Platform Symposium from 17-19th Feb. While there, she will be giving a talk on EpiVax’s immunoinformatics platform on Day 2, 18Feb at 2:30PM. The talk will focus on “The Two-Faced T cell Epitope and Janus Matrix; Relevance to Biologics and ...Read moreAntigen-Specific Immune Tolerance Drug Development Meeting – February 25-27, 2020
Posted on January 31, 2020 by Annie De GrootAntigen-Specific Immune Tolerance Drug Development Meeting - February 25-27, 2020Read moreGordon Research Conference – Advancing Peptides as Tools, Materials and Therapeutics February 9-14, 2020
Posted on January 29, 2020 by Annie De GrootDr. Anne De Groot will be in Ventura Beach, CA for the Gordon Research Center: Advancing Peptides as Tools, Materials and Therapeutics Conference. While there, Annie will be giving a talk on “Immunogenicity of Peptide Drugs and Their Impurities: Taspoglutide Case Study” during the Peptide Pathologes and Vaccines session on Thursday 13Jan at 7:30 PM. If you will ...Read moreAntibodies as Drugs – Keystone Symposia February 2-6, 2020
Posted on January 24, 2020 by Annie De GrootKatie Porter and Sarah Moniz from the Business Development team will be the the Keystone Symposia – Antibodies as Drugs in Santa Fe, New Mexico from February 2-6, 2020. While there, they will be at Poster Session 2 on February 4 with a poster showing the power of EpiVax’s immunogenicity prediction tools with clinical data validation. ...Read moreASM Biothreats January 28-30, 2020
Posted on January 22, 2020 by Annie De GrootEpiVax’s Lauren Meyers will be at the ASM Biothreats in Arlington, VA on January 28-30, 2020. While there, Lauren will be presenting during the Ignite Session on Wednesday Jan 29 from 3:00 – 4:00PM. There she will be presenting EpiVax’s collaborative work: Modulation of Regulatory Immune Responses by Human-Like T Cell Epitopes: Implications for Burkholderia Pseudomallei ...Read moreVaccinology Club of the French Society for Immunology – January 16 -17, 2020
Posted on January 13, 2020 by Annie De GrootOn Thursday 16 and Friday 17 January 2020, Dr. Annie De Groot will be in attendance of the Vaccinology Club of the French Society for Immunology at the Institut Pasteur in Lille, France. There she will be speaking in Session 1 on Thursday 16 January at 10:15AM on Better Epitope Discovery, Precision Immune Engineering and Accelerated ...Read moreWorld Vaccine and Immunotherapy Congress – Dec 2-5, 2019
Posted on November 25, 2019 by Annie De GrootThe annual World Vaccine and Immunotherapy Congress west coast meetings will be held on December 2-5, 2019 at the San Francisco Airport Marriott Waterfront Hotel Dr. Lenny Moise, the Director of Vaccine Research at EpiVax will be in attendance. His talk: “Engineering vaccine antigens to recruit CD4 T cell memory for enhanced antibody responses” will be will ...Read moreBoulder Peptide Symposium – September 23-26, 2019
Posted on September 10, 2019 by Annie De GrootFrom September 23rd to the 26th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Associate Scientific Director of Protein Therapeutics. Dr. Roberts will present two posters on Tuesday September 24th, from 3:30PM – 5:30PM local time. The posters will include a look at our What If Machine ...Read moreEpiVax’s Talks and Presentations in 2019
Posted on August 19, 2019 by Annie De GrootWere you unable to meet the EpiVax team at our last event? No worries! Below is a list of where we will present throughout the year: January 23: Babraham Immunogenicity Seminar (Cambridge, United Kingdom) Hosted by: IONTAS and EpiVax, Inc. Title: Evolution of In Silico Tools for Predicting and In Vitro Assays for Validating T-Cell Response VIEW SLIDE DECK ...Read moreAntibody Engineering & Therapeutics December 9th-13th, 2019
Posted on July 16, 2019 by Annie De GrootAntibody Engineering & Therapeutics Monday, December 9th – Friday, December 13th Marriott Marquis San Diego, California Meet Sarah Moniz, Business Development Associate, at the largest antibody technology meeting, hosted by the Antibody Society, from December 9 to 12 at the Marriott Marquis in San Diego. Learn about EpiVax’s High Throughput Antibody Immunogenicity Prediction tool and report. ABOUT THIS CONFERENCE: Fast-track your ...Read morePEGS Europe November 18th-22nd, 2019
Posted on July 14, 2019 by Annie De Groot11th Annual Protein & Antibody Engineering Summit (PEGS) Europe Monday, November 18th – Friday, November 22nd Lisbon Congress Center Lisbon, Portugal Our European Representative, Paul Von Hoegen, and Business Development Associate, Sarah Moniz, will be present at PEGS Europe. The summit will take place November 18 through November 22 in Lisbon, Portugal. Network with our team and learn about ...Read moreChemical and Biological Defense Science & Technology Conference November 18th-21st, 2019
Posted on July 13, 2019 by Annie De Groot2019 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Hosted by the Defense Threat Reduction Agency (DTRA) Monday, November 18th – Thursday, November 21st Duke Energy Convention Center Cincinnati, Ohio Join Dr. Lenny Moise (Scientific Director of Vaccine Research) as he attends this year’s Chemical and Biological Defense Science & Technology Conference. This event will take place from ...Read moreUPDATED: Immunogenicity and Tolerance Seminar November 15th, 2019
Posted on June 29, 2019 by Annie De GrootUpdated: Thank you to those that joined us for the seminar! It was a successful meeting with many wonderful talks. Please find photos from the event here as well as slide decks from some of our speakers. Welcome to Immunogenicity and Tolerance; Anne De Groot Tregitopes improve murine asthma by promoting highly suppressive and anitgen-specific TRegs; Marieme ...Read moreTIDES Europe November 12th-15th, 2019
Posted on June 28, 2019 by Annie De GrootTIDES Europe: Oligonucleotide and Peptide Therapeutics Tuesday, November 12th – Friday, November 15th RAI Amsterdam Convention Centre Amsterdam, Netherlands Right before our annual Immunogenicity and Tolerance seminar in Amsterdam, you will find us partnering at Europe’s #1 forum for oligonucleotide and peptide leaders, TIDES. Come network with us and learn about our newest technology, PANDA (peptide abbreviated new drug ...Read moreBIO-Europe November 11th-13th, 2019
Posted on June 28, 2019 by Annie De Groot25th Annual International Partnering Conference BIO-Europe Monday, November 11th – Wednesday, November 13th Hamburg Messe East Entrance Hamburg, Germany Network with EpiVax’s Business Development Manager, Katie Porter, and European Representative, Paul Von Hoegen, at BIO-Europe this Fall. Learn about EpiVax’s proprietary immunogenicity assessment tools. INTERESTED IN FORMALLY MEETING? Schedule a one-to-one with us via partneringONE! ABOUT BIO-EUROPE: BIO-Europe is more than just a conference; ...Read moreUPDATE: USP Workshop on Therapeutic Peptides and Oligonucleotides November 4th-5th, 2019
Posted on June 28, 2019 by Annie De GrootUPDATE: Review Dr. Anne De Groots presentation here Therapeutic Peptides and Oligonucleotides: Regulations, Standards and Quality USP Workshop Monday, November 4th – Tuesday, November 5th The U.S. Pharmacopoeia (USP) Therapeutic Peptides and Oligonucleotides: Regulations, Standards and Quality workshop is a 2-day event taking place November 4-5 in Rockville, Maryland. EpiVax’s Dr. De Groot has been invited to speak on ...Read moreAAPS PharmSci360 November 3rd-6th, 2019
Posted on June 28, 2019 by Annie De GrootAAPS 2019 PharmSci360 Sunday, November 3rd – Wednesday, November 6th Henry B. Gonzalez Convention Center San Antonio, Texas Join Dr. De Groot as she attends this year’s AAPS PharmSci360, November 3-6, at the Henry B. Gonzalez Convention Center in San Antonio, Texas. STAY TUNED FOR MORE DETAILS ABOUT HER PRESENTATION! ABOUT AAPS PharmSci360: This event combines all the energy of a large ...Read more